Abstract:ABSTRACT Tuberculous meningitis (TBM) is a severe infectious disease affecting the central nervous system, causing high mortality and disability. However, current diagnostic methods for TBM using cerebrospinal fluid (CSF) lack sensitivity and predictive biomarkers for prognosis. We conducted a study on cytokine profiles in CSF and serum samples from TBM patients to identify disease-specific biomarkers. Patients were categorized into three groups: TBM ( n = 17), cryptococcal meningitis ( n = 10), and non-infection ( n = 6), and cytokine levels were quantified using a 48-plex panel. After treatment, we observed a significant reduction in the levels of 12 cytokines, indicating their potential use as biomarkers for treatment monitoring. Among them, monokine induced by interferon-γ (MIG) and interleukin-18 showed significant differences in serum or CSF cytokine levels compared to the control groups. CSF levels of MIG in TBM patients were negatively correlated with the CSF/blood glucose ratio ( r = −0.4728, P = 0.0475). Positive correlations were found between CSF leukocyte counts and several cytokines, including fibroblast growth factor-basic, granulocyte colony-stimulating factor (G-CSF), monocyte chemotactic protein-3, macrophage inflammatory protein 1 alpha (MIP-1α), and tumor necrosis factor alpha. G-CSF and MIP-1α were also positively correlated with CSF protein levels. Receiver operating characteristic curve analysis revealed that MIG exhibited the highest area under the curve of 0.92 [95% confidence interval (CI) 0.82–1.00] with a sensitivity of 0.85 (95% CI 0.58–0.97) and a specificity of 0.87 (95% CI 0.62–0.98), making it a promising diagnostic biomarker for TBM. Our study provides valuable insights into TBM’s pathogenesis and identifies potential biomarkers for diagnosis and evaluating treatment monitoring. IMPORTANCE Tuberculous meningitis is a life-threatening infection with high mortality and disability rates. Current diagnostic methods using cerebrospinal fluid (CSF) samples have limited sensitivity and lack predictive biomarkers for evaluating prognosis. This study’s findings reveal excessive activation of the immune response during tuberculous meningitis (TBM) infection. Notably, a strong negative correlation was observed between CSF levels of monokine induced by interferon-γ (MIG) and the CSF/blood glucose ratio in TBM patients. MIG also exhibited the highest area under the curve with high sensitivity and specificity. This study suggests that MIG may serve as a novel biomarker for differentiating TBM infection in CSF or serum, potentially leading to improved diagnostic accuracy and better patient outcomes.

Clinical Diagnostic Significance of ESAT-6, IL-10, TNF-α and IFN-γ in Tuberculous Meningitis

Early diagnosis of tuberculous meningitis new methods:detection concentration in cerebrospinal fluid CFP-10 and ESAT-6

A Comparative Evaluation of Enzyme Linked Immunospot Assay and IS6110 Polymerase Chain Reaction for Early Diagnosis of Tuberculous Meningitis

Novel Monoclonal Antibodies To Esat-6 And Cfp-10 Antigens For Elisa-Based Diagnosis Of Pleural Tuberculosis

Clinical Application and Antigenicity of ESAT-6/CFP-10 Fusion Protein in Diagnosis of Tuberculosis

Detection of Interleukin-8, Matrix Metalloproteinase-9 and Interferon Gamma Levels in the Cerebrospinal Fluid of Patients with Tuberculous Meningitis and Viral Meningitis

Study on application of imaging and laboratory detection in early diagnosis of tuberculous meningitis

Systemic and cerebrospinal fluid biomarkers for tuberculous meningitis identification and treatment monitoring

Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis

Comparative Evaluation of Early Diagnosis of Tuberculous Meningitis by Different Assays.

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Diagnostic accuracy of intracellular mycobacterium tuberculosis detection for tuberculous meningitis.

Detection of NSE, MMP-9 and ADA in cerebrospinal fluid applied in diagnosis of tuberculous meningitis

Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

[An Analysis of the Early Diagnostic Criteria for Tuberculosis Meningitis].

Significance of serum and pleural effusion levels of related factors in differential diagnosis of tuberculosis and malignant tumor

Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and Peripheral Blood in Tuberculous Meningitis in China.

Expression of Autophagy-Related Genes in Cerebrospinal Fluid of Patients with Tuberculous Meningitis

Screening the Cytokines for Diagnosis of Tuberculous Meningitis

The Value of Effector T Cells in Patients with Tuberculous Meningitis and Pulmonary Tuberculosis by IFN-γenzyme-linked Immunospot Assay

Positive Interferon-Gamma Release Assay Results Are Correlated With Paradoxical Reaction In Tuberculous Meningitis